author-photo

Thomas Blankenstein

Max Delbrück Center for Molecular Medicine
Charité
Free University of Berlin

216

Papers

10716

Citations

Citation Trend

Filter By

Papers (151) Sort By

Journal Conference Others

The role of CD4 T cells in rejection of solid tumors.

2022 Current Opinion in Immunology
Show All
- Source
- Cite
- Save
Citations (0)
499 A first-in-human, phase 1/2 clinical trial of TK-8001, a MAGE-A1 directed T cell receptor in patients with advanced-stage solid tumors (The “IMAG1NE”-trial)

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
225 Optimal-affinity MAGE-A1-specific T cell receptors (TCRs) generated using the humanized TCR-transgenic mouse platform HuTCR are superior to human donor-derived TCRs

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
95 MAGE-A1 protein expression pattern in > 5,000 tumor and healthy tissue samples: Validation of MAGE-A1 as an ideal target for TCR-based cell therapy

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Clonally Expanded Bone Marrow T Cells Show Effector Differentiation and Rarely Recognize Disease-Associated Antigens in Multiple Myeloma

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
SigsPack , a package for cancer mutational signatures

2019 BMC Bioinformatics
Show All
- Source
- Cite
- Save
Citations (8)
Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer

2019 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (11)
A Transgenic Dual-Luciferase Reporter Mouse for Longitudinal and Functional Monitoring of T Cells In Vivo

2018 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (10)
Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus

2018 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (10)
Effective NY-ESO-1–specific MHC II–restricted T cell receptors from antigen-negative hosts enhance tumor regression

2018 Journal of Clinical Investigation
Show All
- Source
- Cite
- Save
Citations (7)